Capricor, Inc.
✓ AI-Ready Profile73
AI Score
🤖 AI-Optimized Summary
Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. At the forefront of our innovation is our lead product candidate, Deramiocel, an allogeneic cardiac-derived cell therapy that is currently in late-stage development for the treatment of Duchenne muscular dystrophy (DMD). Capricor is also developing its exosome technology as a next-generation therapeutic pl
📋 Business Details
Is this your business?
Claim this profile to improve your AI Visibility Score and get verified.
Claim My AI Profile →